Money
Biomatter Secures €16.2 Million for AI-Driven Enzyme Development
Lithuanian biotech startup Biomatter has raised €16.2 million to scale its AI-powered enzyme design platform and build a new R&D facility in Vilnius.
November 12, 2026, 10:48 AM·EU-Startups
